1. Home
  2. TCBP vs JTAI Comparison

TCBP vs JTAI Comparison

Compare TCBP & JTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TCBP
  • JTAI
  • Stock Information
  • Founded
  • TCBP 2013
  • JTAI 2018
  • Country
  • TCBP United Kingdom
  • JTAI United States
  • Employees
  • TCBP N/A
  • JTAI N/A
  • Industry
  • TCBP Biotechnology: Biological Products (No Diagnostic Substances)
  • JTAI Blank Checks
  • Sector
  • TCBP Health Care
  • JTAI Finance
  • Exchange
  • TCBP Nasdaq
  • JTAI Nasdaq
  • Market Cap
  • TCBP 3.0M
  • JTAI 3.4M
  • IPO Year
  • TCBP 2022
  • JTAI N/A
  • Fundamental
  • Price
  • TCBP $0.65
  • JTAI $3.95
  • Analyst Decision
  • TCBP Strong Buy
  • JTAI
  • Analyst Count
  • TCBP 1
  • JTAI 0
  • Target Price
  • TCBP $3.00
  • JTAI N/A
  • AVG Volume (30 Days)
  • TCBP 1.8M
  • JTAI 1.2M
  • Earning Date
  • TCBP 02-09-2025
  • JTAI 11-14-2024
  • Dividend Yield
  • TCBP N/A
  • JTAI N/A
  • EPS Growth
  • TCBP N/A
  • JTAI N/A
  • EPS
  • TCBP N/A
  • JTAI N/A
  • Revenue
  • TCBP N/A
  • JTAI $15,028,926.00
  • Revenue This Year
  • TCBP N/A
  • JTAI $21.49
  • Revenue Next Year
  • TCBP N/A
  • JTAI $10.05
  • P/E Ratio
  • TCBP N/A
  • JTAI N/A
  • Revenue Growth
  • TCBP N/A
  • JTAI 46.66
  • 52 Week Low
  • TCBP $0.44
  • JTAI $3.51
  • 52 Week High
  • TCBP $41.50
  • JTAI $731.25
  • Technical
  • Relative Strength Index (RSI)
  • TCBP 36.84
  • JTAI 31.95
  • Support Level
  • TCBP $0.45
  • JTAI $3.64
  • Resistance Level
  • TCBP $0.70
  • JTAI $5.10
  • Average True Range (ATR)
  • TCBP 0.08
  • JTAI 0.65
  • MACD
  • TCBP 0.10
  • JTAI 0.51
  • Stochastic Oscillator
  • TCBP 55.58
  • JTAI 18.86

About TCBP TC BioPharm (Holdings) plc

TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

About JTAI Jet.AI Inc.

Jet AI Inc is principally involved in the sale of jet cards, which enable holders to use certain aircraft owned, leased by, arranged, and/or managed by Jet Token and others at agreed-upon rates, as well as the sale of fractional interests in aircraft; and the operation of a proprietary booking platform, which functions as a prospecting and quoting platform to arrange private jet travel with third party carriers as well as via Jet Token's leased and managed aircraft.

Share on Social Networks: